Esaxerenone for nocturnal hypertension and possible future direction for treatment of hypertension-cardiovascular-kidney comorbidity

被引：4
作者：
Tamura, Kouichi [1 ]
Kanaoka, Tomohiko [1 ]
Fujiwara, Naoki [1 ]
Hirota, Keigo [1 ]
机构：
[1] Yokohama City Univ, Dept Med Sci & Cardiorenal Med, Grad Sch Med, Yokohama, Japan
来源：
HYPERTENSION RESEARCH | 2023年 / 46卷 / 08期
关键词：
Esaxerenone; Mineralocorticoid receptor antagonist; Nocturnal hypertension; Cardiorenal syndrome; Vascular stiffness; MINERALOCORTICOID RECEPTOR; PHASE-3; CS-3150;
D O I：
10.1038/s41440-023-01338-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2059 / 2061
页数：3
相关论文
共 25 条
  • [1] Diabetic Kidney Disease Challenges, Progress, and Possibilities
    Alicic, Radica Z.
    Rooney, Michele T.
    Tuttle, Katherine R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12): : 2032 - 2045
  • [2] Heart failure drug treatment: the fantastic four
    Bauersachs, Johann
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (06) : 681 - 683
  • [3] Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism
    Haze, Tatsuya
    Ozawa, Moe
    Kawano, Rina
    Haruna, Aiko
    Ohki, Yuki
    Suzuki, Shota
    Kobayashi, Yusuke
    Fujiwara, Akira
    Saka, Sanae
    Tamura, Kouichi
    Hirawa, Nobuhito
    [J]. HYPERTENSION RESEARCH, 2023, 46 (05) : 1132 - 1144
  • [4] Is esaxerenone the ultimate mineralocorticoid receptor antagonist? COMMENT
    Hoshide, Satoshi
    [J]. HYPERTENSION RESEARCH, 2023, 46 (02) : 516 - 517
  • [5] Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function
    Imaizumi, Takahiro
    Fujii, Naohiko
    Hamano, Takayuki
    Yang, Wei
    Taguri, Masataka
    Kansal, Mayank
    Mehta, Rupal
    Shafi, Tariq
    Taliercio, Jonathan
    Go, Alan
    Rao, Panduranga
    Hamm, L. Lee
    Deo, Rajat
    Maruyama, Shoichi
    Fukagawa, Masafumi
    Feldman, Harold I.
    [J]. KIDNEY INTERNATIONAL, 2023, 103 (05) : 949 - 961
  • [6] Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN) Phase 3 Randomized Controlled Clinical Trial
    Ito, Sadayoshi
    Kashihara, Naoki
    Shikata, Kenichi
    Nangaku, Masaomi
    Wada, Takashi
    Okuda, Yasuyuki
    Sawanobori, Tomoko
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1715 - 1727
  • [7] Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
    Ito, Sadayoshi
    Itoh, Hiroshi
    Rakugi, Hiromi
    Okuda, Yasuyuki
    Yoshimura, Motonobu
    Yamakawa, Satoru
    [J]. HYPERTENSION, 2020, 75 (01) : 51 - 58
  • [8] Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study
    Itoh, Hiroshi
    Ito, Sadayoshi
    Rakugi, Hiromi
    Okuda, Yasuyuki
    Nishioka, Satoshi
    [J]. HYPERTENSION RESEARCH, 2019, 42 (10) : 1572 - 1581
  • [9] Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database
    Kadowaki, Takashi
    Komuro, Issei
    Morita, Naru
    Akiyama, Hiroki
    Kidani, Yoko
    Yajima, Toshitaka
    [J]. DIABETES THERAPY, 2022, 13 (02) : 275 - 286
  • [10] Age-Dependent Association Between Modifiable Risk Factors and Incident Cardiovascular Disease
    Kaneko, Hidehiro
    Yano, Yuichiro
    Okada, Akira
    Itoh, Hidetaka
    Suzuki, Yuta
    Yokota, Isao
    Morita, Kojiro
    Fujiu, Katsuhito
    Michihata, Nobuaki
    Jo, Taisuke
    Yamaguchi, Satoko
    Takeda, Norifumi
    Morita, Hiroyuki
    Node, Koichi
    Yamauchi, Toshimasa
    Nangaku, Masaomi
    Kadowaki, Takashi
    McEvoy, John W.
    Lam, Carolyn S. P.
    Yasunaga, Hideo
    Komuro, Issei
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (02):
123